Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash equival ...

Under the proposal, Fannie Mae and Freddie Mac will purchase $200 billion worth of mortgage bonds.

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

Founded by Devashish Singh and Saurab Jain in 2021, Chennai-headquartered MrMed operates a digital platform that connects patients directly to verified suppliers of speciality medicines.

Detailed price information for Halozyme Therapeutic (HALO-Q) from The Globe and Mail including charting and trades.

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

I don’t know about you, but I’ve always preferred making my own antibodies. Why outsource it? It’s so handy letting my own body do the work of fighting infections while I’m writing articles or ...